Traumakine Data Presented at MHSR Symposium
Faron Pharmaceuticals Ltd. (“Faron” or “Company”) Traumakine Data on Multi-Organ Dysfunction and Limb Salvage to be Presented at the Military Health System Research Symposium · Data further highlights promise of intravenous interferon beta-1a therapy as potential therapeutic for emergency and trauma patients, especially when given early on · Primates treated with Traumakine at the time of major inflammation due to ischemia showed lower levels of muscle and liver damage markers indicating total body protection · Full restoration of limb function seen with no